Search filters

List of works by Daniel E. Singer

A New Risk Scheme to Predict Ischemic Stroke and Other Thromboembolism in Atrial Fibrillation: The ATRIA Study Stroke Risk Score ⬇️

scientific article published on June 21, 2013

A Post-Discharge Smoking-Cessation Intervention for Hospital Patients: Helping Hand 2 Randomized Clinical Trial

scientific article published on October 2016

A new era in stroke prevention for atrial fibrillation: comment on "current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation

scientific article published on 01 April 2012

A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study

scientific article

Absence of Oral Anticoagulation and Subsequent Outcomes Among Outpatients with Atrial Fibrillation

scientific article published on 22 November 2016

Adding rigor to stroke risk prediction in atrial fibrillation

scientific article published in January 2015

Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012

scientific article

Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation

scientific article (publication date: 16 November 2004)

Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study

scientific article published on August 2006

Alternative calculations of individual patient time in therapeutic range while taking warfarin: results from the ROCKET AF trial

scientific article

Anticoagulation for atrial fibrillation

scientific article (publication date: February 2004)

Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?

scientific article (publication date: 26 November 2003)

Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

scientific article published on February 2012

Antithrombotic therapy for stroke prevention in atrial fibrillation

scientific article

Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

scientific article

Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

scientific article (publication date: September 2004)

Anxiety, Depression, and Adverse Clinical Outcomes in Patients With Atrial Fibrillation Starting Warfarin: Cardiovascular Research Network WAVE Study.

scientific article published on 14 April 2018

Are patients more likely to see physicians of the same sex? Recent national trends in primary care medicine

scientific article

Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation

scientific article published on 03 July 2019

Association between antibiotic prescribing and visit duration in adults with upper respiratory tract infections.

scientific article published on September 2003

Association of Atrial Fibrillation Clinical Phenotypes with Treatment Patterns and Outcomes: A Multicenter Registry Study

scientific article

Association of E-Cigarette Use With Smoking Cessation Among Smokers Who Plan to Quit After a Hospitalization: A Prospective Study

scientific article published on 27 March 2018

Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II

scientific article published on 01 December 2018

Atrial Fibrillation Burden and Short-Term Risk of Stroke: Case-Crossover Analysis of Continuously Recorded Heart Rhythm From Cardiac Electronic Implanted Devices

scientific article published on 14 July 2015

Automated Electronic Phenotyping of Cardioembolic Stroke

scientific article published on 10 December 2020

B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation

scientific article published on 18 September 2018

Blood pressure control and stroke or bleeding risk in anticoagulated patients with atrial fibrillation: Results from the ROCKET AF Trial

scientific article published on 6 May 2016

Bupropion for smokers hospitalized with acute cardiovascular disease.

scientific article published in December 2006

CHA2DS2-VASc risk scheme: not ready for clinical use

scientific article published on 01 October 2010

Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis

scientific article (publication date: July 2003)

Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry.

scientific article published in September 2017

Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF

scientific article

Challenges to the effective use of unfractionated heparin in the hospitalized management of acute thrombosis

scientific article published in March 2003

Changes in Use of Anticoagulation in Patients With Atrial Fibrillation Within a Primary Care Network Associated With the Introduction of Direct Oral Anticoagulants

scientific article published on 15 June 2017

Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation

scientific article published on 06 June 2018

Clinical Outcomes With Rivaroxaban in Patients Transitioned From Vitamin K Antagonist Therapy

article

Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial

scientific article

Comparative Effectiveness of Post-Discharge Strategies for Hospitalized Smokers: study protocol for the Helping HAND 2 randomized controlled trial

scientific article

Comparative effectiveness of post-discharge interventions for hospitalized smokers: study protocol for a randomized controlled trial ⬇️

scientific article published on August 1, 2012

Comparative effectiveness of post-discharge strategies for hospitalized smokers: Study protocol for the Helping HAND 4 randomized controlled trial

scientific article published on 16 April 2020

Comparison of Long-Term Adverse Outcomes in Patients With Atrial Fibrillation Having Ablation Versus Antiarrhythmic Medications

scientific article published on 19 November 2019

Comparison of Patient-Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT - AF Registry

Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).

scientific article published on 12 October 2014

Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation

scientific article published on February 2008

Comparison of the ATRIA, CHADS2, and CHA2DS2-VASc stroke risk scores in predicting ischaemic stroke in a large Swedish cohort of patients with atrial fibrillation

scientific article

Correction to: Comparative effectiveness of post-discharge strategies for hospitalized smokers: Study protocol for the Helping HAND 4 randomized controlled trial

scientific article published on 04 May 2020

Death and disability from warfarin-associated intracranial and extracranial hemorrhages

scientific article published on 24 May 2007

Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillation

scientific article published on 07 January 2020

Defining Clinically Important Difference in the Atrial Fibrillation Effect on Quality-of-Life Score

scientific article published on 01 May 2019

Design and rationale of a pragmatic trial integrating routine screening for atrial fibrillation at primary care visits: The VITAL-AF trial

scientific article published on 22 June 2019

Desire for antibiotics and antibiotic prescribing for adults with upper respiratory tract infections.

scientific article

Detection of Previously Undiagnosed Atrial Fibrillation in Patients With Stroke Risk Factors and Usefulness of Continuous Monitoring in Primary Stroke Prevention ⬇️

scientific article published on July 20, 2012

Development and validation of a new health-related quality of life instrument for patients with sinusitis

scientific article

Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices).

scientific article published on 11 December 2013

Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study

scientific article

Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Tr

scientific article

Disease understanding in patients newly diagnosed with atrial fibrillation

scientific article

Disparities in Cancer Incidence, Stage, and Mortality at Boston Health Care for the Homeless Program

scientific article

Disparities in Quality of Primary Care by Resident and Staff Physicians: Is There a Conflict Between Training and Equity?

scientific article published on 08 April 2019

Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation

scientific article

Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study

scientific article

Effect of Temporary Interruption of Warfarin Due to an Intervention on Downstream Time in Therapeutic Range in Patients With Atrial Fibrillation (from ORBIT AF)

scientific article published on 12 July 2020

Effect of Variation in Published Stroke Rates on the Net Clinical Benefit of Anticoagulation for Atrial Fibrillation

scientific article published on 25 September 2018

Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators

scientific article published on 29 January 2009

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation

scientific article (publication date: 11 September 2003)

Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin

scientific article published on 05 June 2014

Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial).

scientific article

Efficacy and Safety of Rivaroxaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation and a History of Cancer: Observations from ROCKET AF

article by Sean T Chen et al published 14 September 2018 in European heart journal. Quality of care & clinical outcomes

Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Em

scientific article

Efficacy and safety of rivaroxaban compared with warfarin in patients with carotid artery disease and nonvalvular atrial fibrillation: Insights from the ROCKET AF trial.

scientific article published in February 2018

Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AF.

scientific article

Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: The Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial F

article by Sameer Bansilal et al published October 2015 in American Heart Journal

Efficacy and safety of rivaroxaban in patients with heart failure and nonvalvular atrial fibrillation: insights from ROCKET AF.

scientific article published on 30 May 2013

Efficacy and safety of rivaroxaban versus warfarin in patients from mainland China with nonvalvular atrial fibrillation: A subgroup analysis from the ROCKET AF trial

scientific article published on 13 April 2017

Electronic physician notifications to improve guideline-based anticoagulation in atrial fibrillation: a randomized controlled trial

scientific article published on 03 August 2018

End of study transition from study drug to open-label vitamin K antagonist therapy: the ROCKET AF experience

scientific article

Evaluating area-based socioeconomic status indicators for monitoring disparities within health care systems: results from a primary care network

scientific article

Examining the effects of illicit drug use on tobacco cessation outcomes in the Helping HAND 2 randomized controlled trial

scientific article

Factor V Leiden and risk of ischemic stroke in nonvalvular atrial fibrillation: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

scientific article published in February 2003

Factors Associated with Large Improvements in Health-Related Quality of Life in Patients with Atrial Fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)

scientific article published on 16 April 2020

Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation).

scientific article

Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).

scientific article

First Diagnosis of Atrial Fibrillation at the Time of Stroke

scientific article published on 17 February 2017

Food insufficiency and health services utilization in a national sample of homeless adults

scientific article

Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II).

scientific article published on 16 February 2018

Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin: ROCKET AF Trial.

scientific article

Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study

scientific article

Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillation

scientific article published on 08 November 2019

Health Literacy and Awareness of Atrial Fibrillation

scientific article published on 11 April 2017

Health-related quality of life of adults with upper respiratory tract infections

scientific article

Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial

scientific article

Hospitalizations in patients with atrial fibrillation: an analysis from ROCKET AF

scientific article published on 12 May 2016

How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?

scientific article published on 15 June 2016

How well does physician risk assessment predict stroke and bleeding in atrial fibrillation? Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

scientific article published on 27 August 2016

Human Immunodeficiency Virus (HIV) Quality Indicators Are Similar Across HIV Care Delivery Models

scientific article

Identifying patients with high data completeness to improve validity of comparative effectiveness research in electronic health records data

scientific article published on 02 September 2017

Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial

scientific article

Impact of polyvascular disease on patients with atrial fibrillation: Insights from ROCKET AF

article by Sean T. Chen et al published June 2018 in American Heart Journal

Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study

scientific article published on 02 March 2009

Improvements in health-related quality of life among smokers who quit after hospitalization.

scientific article published on 7 February 2018

Incidence of newly detected atrial arrhythmias via implantable devices in patients with a history of thromboembolic events

scientific article published on 31 December 2009

Incremental prognostic value of renal function for stroke prediction in atrial fibrillation

scientific article published on 25 July 2018

Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.

scientific article published on 12 November 2016

Influence of Kidney Function Estimation Methods on Eligibility for Edoxaban Population Impact of the US Food and Drug Administration's Approach for Its Product Labeling

scientific article

Initial Precipitants and Recurrence of Atrial Fibrillation

scientific article published on 12 February 2020

Interactive Voice Response Calls to Promote Smoking Cessation after Hospital Discharge: Pooled Analysis of Two Randomized Clinical Trials

scientific article published on 14 June 2017

Intracranial Hemorrhage Among Patients With Atrial Fibrillation Anticoagulated With Warfarin or Rivaroxaban

article

Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial

scientific article published on 15 October 2013

Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry

scientific article

Limited English Proficient Patients and Time Spent in Therapeutic Range in a Warfarin Anticoagulation Clinic ⬇️

scientific article published on 05 July 2013

Long-term outcomes of surgical and nonsurgical management of lumbar spinal stenosis: 8 to 10 year results from the maine lumbar spine study

scientific article

Long-term outcomes of surgical and nonsurgical management of sciatica secondary to a lumbar disc herniation: 10 year results from the maine lumbar spine study

scientific article

Long-term survival after ischemic stroke in patients with atrial fibrillation

scientific article published on 14 February 2014

Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial

scientific article

Measures of health-related quality of life for adults with acute sinusitis. A systematic review

scientific article

Methodologic Differences Across Studies of Patients With Atrial Fibrillation Lead to Varying Estimates of Stroke Risk

scientific article published on 09 June 2018

Mortality among homeless adults in Boston: shifts in causes of death over a 15-year period

scientific article published on February 2013

Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation

scientific article

National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation

scientific article

Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban

scientific article published on 17 February 2016

Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation

scientific article published on 11 November 2019

Net clinical benefit of rivaroxaban compared with warfarin in atrial fibrillation: Results from ROCKET AF.

scientific article published in April 2018

Noncentral Nervous System Systemic Embolism in Patients With Atrial Fibrillation: Results From ROCKET AF (Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atr

scientific article published in May 2017

Novel oral anticoagulants and reversal agents: Considerations for clinical development

scientific article published on 26 March 2015

Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II Registry

scientific article published on December 2016

On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF.

scientific article published on July 2016

Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis

scientific article (publication date: 20 November 2002)

Oral anticoagulants vs. aspirin for stroke prevention in patients with non-valvular atrial fibrillation: the verdict is in

scientific article (publication date: December 2003)

Out-of-system care and recording of patient characteristics critical for comparative effectiveness research

scientific article published on 26 December 2017

Outcome of Patients Receiving Thrombolytic Therapy While on Rivaroxaban for Nonvalvular Atrial Fibrillation (from Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial i

Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial

scientific article published on 14 March 2013

Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation

scientific article published on 13 December 2019

Outcomes of Cardiac Catheterization in Patients With Atrial Fibrillation on Anticoagulation in Contemporary in Practice: An Analysis of the ORBIT II Registry

scientific article published on 15 May 2020

Outcomes of Dabigatran and Warfarin for Atrial Fibrillation in Contemporary Practice: A Retrospective Cohort Study

scientific article published on 14 November 2017

Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Preven

scientific article published on February 2013

Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention o

scientific article

Patient-Reported Satisfaction and Study Drug Discontinuation: Post-Hoc Analysis of Findings from ROCKET AF

scientific article published on 02 August 2019

Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry

scientific article published on April 2015

Patterns of amiodarone use and outcomes in clinical practice for atrial fibrillation

scientific article published on 23 October 2019

Patterns of oral anticoagulation use with cardioversion in clinical practice

scientific article published on 26 June 2020

Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT-AF

scientific article published on 01 September 2018

Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry

scientific article

Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation

scientific article published on 16 December 2015

Prediction Score for Anticoagulation Control Quality Among Older Adults

scientific article published on 5 October 2017

Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT-AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation).

scientific article published on 22 December 2017

Profile of Patients Diagnosed with Acute Venous Thromboembolism in Routine Clinical Practice: The RE-COVERY DVT/PE™ Study

scientific article published on 20 April 2020

Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study

scientific article published on 26 August 2020

Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients With Atrial Fibrillation

scientific article published on 01 August 2018

Putting risk prediction in atrial fibrillation into perspective ⬇️

scientific article published on February 29, 2012

RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate

scientific article published on 17 November 2016

Rationale and design of a large population study to validate software for the assessment of atrial fibrillation from data acquired by a consumer tracker or smartwatch: The Fitbit heart study

scientific article published on 16 April 2021

Rationale and design of a prospective study of the clinical significance of atrial arrhythmias detected by implanted device diagnostics: the TRENDS study

scientific article published in January 2006

Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

scientific article published on 11 July 2014

Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index (from Patients Treated With Rivaroxaban and Warfarin in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention o

Relationship between time in therapeutic range and comparative treatment effect of rivaroxaban and warfarin: results from the ROCKET AF trial

scientific article

Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin

scientific article published on 03 December 2012

Reply: Recent Diabetes and Atrial Fibrillation Report Diverges From Pre-Existing Evidence

scientific article published on 01 May 2016

Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".

scientific article published in July 2016

Response to Letter Regarding Article, “Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation: Validation of the R 2 CHADS 2 Index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Fac

article by Jonathan P Piccini et al published 10 September 2013 in Circulation

Reversal strategies and outcomes in patients with atrial fibrillation and warfarin-associated intracranial hemorrhage

scientific article published on 24 May 2020

Risk factors for medication non-adherence among atrial fibrillation patients

scientific article published on 11 February 2019

Risk of Ischemic Stroke and Major Bleeding in Patients with Atrial Fibrillation and Cancer

scientific article published on 27 December 2019

Risk of major cardiovascular and neurologic events with obstructive sleep apnea among patients with atrial fibrillation

scientific article published on 07 January 2020

Risks and Benefits of Anticoagulation in Atrial Fibrillation

Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF ⬇️

scientific article published on March 7, 2012

Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trial

scientific article published on 24 April 2014

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Safety and Efficacy of Rivaroxaban in Patients With Cardiac Implantable Electronic Devices: Observations From the ROCKET AF Trial

scientific article published on 14 June 2017

Selective Serotonin Reuptake Inhibitors and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial

article

Shared Decision Making in Atrial Fibrillation: Patient-Reported Involvement in Treatment Decisions

scientific article published on 11 May 2020

Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study

scientific article

Smoking Cessation After Hospital Discharge: Factors Associated With Abstinence

scientific article published on 29 August 2018

Stability of High-Quality Warfarin Anticoagulation in a Community-Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

scientific article published on 22 July 2016

Stroke Rate Variation and Anticoagulation Benefit in Atrial Fibrillation

Stroke Risk and Treatment in Patients with Atrial Fibrillation and Low CHADS-VASc Scores: Findings From the ORBIT-AF I and II Registries

article published in 2018

Stroke prevention in atrial fibrillation in older adults: existing knowledge gaps and areas for innovation: a summary of an American Federation for Aging research seminar

scientific article published on 19 September 2013

Stroke prevention in atrial fibrillation: another step sideways

scientific article published in January 2008

Sustained care intervention and postdischarge smoking cessation among hospitalized adults: a randomized clinical trial.

scientific article published in August 2014

The Maine-Seattle back questionnaire: a 12-item disability questionnaire for evaluating patients with lumbar sciatica or stenosis: results of a derivation and validation cohort analysis

scientific article

The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation

scientific article published in November 1990

The effect of surgical and nonsurgical treatment on longitudinal outcomes of lumbar spinal stenosis over 10 years

scientific article

The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage

scientific article published in April 2004

The impact of disability compensation on long-term treatment outcomes of patients with sciatica due to a lumbar disc herniation

scientific article published on 01 December 2006

The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation

scientific article published in November 2009

The net clinical benefit of warfarin anticoagulation in atrial fibrillation

scientific article published on September 2009

The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study

scientific article published on 4 August 2009

The unmet health care needs of homeless adults: a national study

scientific article published on 13 May 2010

Thirty-Day Mortality After Ischemic Stroke and Intracranial Hemorrhage in Patients With Atrial Fibrillation On and Off Anticoagulants ⬇️

scientific article published on April 26, 2012

Tobacco-, alcohol-, and drug-attributable deaths and their contribution to mortality disparities in a cohort of homeless adults in Boston

scientific article published on 18 December 2014

Treatment Consistency Across Levels of Baseline Renal Function With Rivaroxaban or Warfarin: A ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atr

scientific article

Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation II

scientific article published on 24 April 2019

Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease

scientific article

Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry

scientific article published on 16 July 2013

Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trial

scientific article

Use of Dual Antiplatelet Therapy and Patient Outcomes in Those Undergoing Percutaneous Coronary Intervention: The ROCKET AF Trial.

scientific article

Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.

scientific article published on 30 December 2016

Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trial

scientific article published on 22 June 2016

Validity of a new health-related quality of life instrument for patients with chronic sinusitis

scientific article published in May 2005

Warfarin Discontinuation After Starting Warfarin for Atrial Fibrillation ⬇️

scientific article published on October 19, 2010

Wide Variation in Reported Rates of Stroke Across Cohorts of Patients With Atrial Fibrillation

scientific article published on 31 October 2016

Paulina is supported by:

About Paulina

Help